Innocoll Announces Provisional Findings from its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections

Innocoll Announces Provisional Findings from its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections (more)

New therapies, including novel biologic agents from Elan/Wyeth and Eli Lilly, will drive robust 11 percent annual growth in the Alzheimer’s Disease market

Sales of Acetylcholinesterase Inhibitors, which currently dominate the market, will decline by $1 billion from 2008 to 2018, according to a new report from Decision Resources (more)

WORLDiscoveries appoints executive director

Local business leader Paul Paolatto has been appointed Executive Director of the WORLDiscoveries technology transfer consortium set up to commercialize research at The University of Western Ontario, Robarts Research Institute and Lawson HRI (more)

Penwest Enters Into Third Research and Development Agreement With Otsuka Pharmaceutical

Third oral controlled release deal with Otsuka Pharmaceutical (more)

Despite generic erosion of key brands, the Hospital-Acquired Gram Negative Infections drug market will increase by $1 billion from 2008 to 2018

Uptake of novel agents from Novexel, Johnson & Johnson and Wyeth will drive growth, according to a new report from Decision Resources (more)

Global network formed to improve hearing implant outcomes

The Cochlear Implant Program at the London Health Sciences Centre (LHSC) working in collaboration with researchers at The University of Western Ontario's National Centre for Audiology, has joined 16 other world-class centres to form HEARRING - the Interna (more)

Brescia student honored for groundbreaking nutrition research

Brescia University College student Jaimie Hemsworth's work in developing and testing supplemented probiotic yogurt for HIV clients has earned her the Morgan Medal for research from the Canadian Foundation for Dietetic Research. (more)

Exploring the link between HPV and head and neck cancers

Dr. Maura Gillison will present “The impact of HPV on prevention, screening and treatment of head and neck cancers” as part of the 6th Annual Research & Education Day by the Dept of Oncology at Western’s Schulich School of Medicine, June 12. (more)

Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand

Agreement Demonstrates Value of OPANA ER in Markets Outside U.S. (more)

Growth in the Parkinson’s Disease drug market, fueled by the launch of several new therapies, will be offset by generic erosion of key agents

Overall market will increase by a modest $300 million from 2008 to 2018, according to a new report from Decision Resources (more)